JP2016540798A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540798A5
JP2016540798A5 JP2016540038A JP2016540038A JP2016540798A5 JP 2016540798 A5 JP2016540798 A5 JP 2016540798A5 JP 2016540038 A JP2016540038 A JP 2016540038A JP 2016540038 A JP2016540038 A JP 2016540038A JP 2016540798 A5 JP2016540798 A5 JP 2016540798A5
Authority
JP
Japan
Prior art keywords
opioid
active ingredient
pharmacologically active
nsaid
cox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016540038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016540798A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/077748 external-priority patent/WO2015091352A1/en
Publication of JP2016540798A publication Critical patent/JP2016540798A/ja
Publication of JP2016540798A5 publication Critical patent/JP2016540798A5/ja
Pending legal-status Critical Current

Links

JP2016540038A 2013-12-16 2014-12-15 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形 Pending JP2016540798A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13197503 2013-12-16
EP13197503.9 2013-12-16
PCT/EP2014/077748 WO2015091352A1 (en) 2013-12-16 2014-12-15 Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019107622A Division JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Publications (2)

Publication Number Publication Date
JP2016540798A JP2016540798A (ja) 2016-12-28
JP2016540798A5 true JP2016540798A5 (OSRAM) 2018-12-06

Family

ID=49882823

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016540038A Pending JP2016540798A (ja) 2013-12-16 2014-12-15 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形
JP2019107622A Withdrawn JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019107622A Withdrawn JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Country Status (7)

Country Link
US (3) US20150164807A1 (OSRAM)
EP (1) EP3082781A1 (OSRAM)
JP (2) JP2016540798A (OSRAM)
AU (1) AU2014365038B2 (OSRAM)
CA (1) CA2933983A1 (OSRAM)
MX (1) MX2016007848A (OSRAM)
WO (1) WO2015091352A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201502077D0 (en) * 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd Improved hme technology

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
AU3024399A (en) 1998-04-03 1999-10-25 Bm Research A/S Controlled release composition
US7141250B2 (en) 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
EP1610768B1 (en) 2003-03-26 2008-07-02 Egalet A/S Matrix compositions for controlled delivery of drug substances
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DK1658054T3 (da) 2003-08-06 2007-10-01 Gruenenthal Gmbh Indgivelsesform, som er sikret mod misbrug
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10360792A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
JP5064209B2 (ja) 2004-04-22 2012-10-31 グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 乱用防止固体剤形を製造する方法
WO2006002883A1 (de) 2004-07-01 2006-01-12 Grünenthal GmbH Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreichungsform unter verwendung eines planetwalzenextruders
JP5259183B2 (ja) 2004-07-01 2013-08-07 グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 乱用に対して保護された経口剤形
AR053304A1 (es) 2004-07-01 2007-05-02 Gruenenthal Gmbh Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
JP4563787B2 (ja) * 2004-12-10 2010-10-13 日立プラズマディスプレイ株式会社 プラズマディスプレイ装置及びその制御方法
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2611081C (en) 2005-06-03 2016-05-31 Egalet A/S A drug delivery system for delivering active substances dispersed in a dispersion medium
US20090022798A1 (en) 2007-07-20 2009-01-22 Abbott Gmbh & Co. Kg Formulations of nonopioid and confined opioid analgesics
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
SG169334A1 (en) * 2006-01-21 2011-03-30 Abbott Gmbh & Co Kg Dosage form and method for the delivery of drugs of abuse
US20100172989A1 (en) 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
EP2104493A2 (en) 2007-01-16 2009-09-30 Egalet A/S Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
ES2963291T3 (es) * 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
CA2713128C (en) * 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
CN107028908A (zh) * 2008-10-27 2017-08-11 阿尔扎公司 对乙酰氨基酚/曲马多口服延释剂型
AU2010206376B2 (en) 2009-01-26 2012-10-18 Egalet Ltd. Controlled release formulations with continuous efficacy
ES2607209T3 (es) 2009-02-06 2017-03-29 Egalet Ltd. Composiciones farmacéuticas resistentes al abuso
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations
CN102573805A (zh) * 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
DK2838512T3 (en) * 2012-04-18 2018-11-19 Gruenenthal Gmbh MANIPULATED AND DOSAGE DUMPED PHARMACEUTICAL DOSAGE FORM
US10064945B2 (en) * 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc

Similar Documents

Publication Publication Date Title
NO2026009I1 (no) vimseltinib, optionally in the form of a pharmaceutically acceptable salt
JP2015147774A5 (OSRAM)
JP2013173781A5 (OSRAM)
CN109843873A (zh) 炔代杂环化合物、其制备方法及其在医药学上的应用
JP2016503708A5 (OSRAM)
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
JP2014237817A5 (OSRAM)
JP2016502172A5 (OSRAM)
JP2015520667A5 (OSRAM)
JP2017505494A5 (OSRAM)
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
JP2016540360A5 (ja) 基板処理システム及び基板処理方法
WO2014153495A9 (en) Novel stat3 inhibitors
JP2017197541A5 (OSRAM)
JP2014529579A5 (OSRAM)
JP2015529327A5 (OSRAM)
JP2017147380A5 (OSRAM)
JP2017077228A5 (ja) 移動式搾乳装置および該移動式搾乳装置を使用した放牧方法
CN105764509A (zh) 达比加群酯或其盐的投药制剂及其制备方法
JP2015208765A5 (OSRAM)
JP2016531187A5 (OSRAM)
JP2014239805A5 (OSRAM)
刘倩君 Gable City
Puhr Finding Contentment Somewhere between Jean-Paul Sartre and the Huainanzi
宋炯炯 The First Piano Sonata of Rachmaninoff